Sign up to our newsletter Subscribe
Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

Value-Based Pricing (VBP) aligns the price of a treatment with the value it provides to patients, healthcare systems, and society. Across multiple indications, a single price may not accurately reflect a medicine’s value, Indication-Based Pricing (IBP) allows different prices to be set for different indications.